Droxidopa for the Short-Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B)

Droxidopa for neurogenic orthostatic hypotension: A randomized, placebo-controlled, phase 3 trial

(2014) H. Kaufmann et al.   NEUROLOGY

The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale

(2011) Horacio Kaufmann et al.   CLINICAL AUTONOMIC RESEARCH

Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome

(2011) Roy Freeman et al.   CLINICAL AUTONOMIC RESEARCH

The prevalence of symptomatic orthostatic hypotension in patients with Parkinson’s disease and atypical parkinsonism

(2011) Ainhi D. Ha et al.   PARKINSONISM & RELATED DISORDERS

Understanding inconsistencies in patient-reported outcomes after spine treatment: response shift phenomena

(2009) Carolyn E. Schwartz et al.   Spine Journal

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS

Neurogenic Orthostatic Hypotension

(2008) Roy Freeman   NEW ENGLAND JOURNAL OF MEDICINE